20152 ⎘
Medicinal preparations characterised by special physical form; Preparations in capsules, e.g. of gelatin, of chocolate; Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals; Wall or coating material; Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
Biodegradable Microcapsules Containing Filling Material
#302Dendrimers for sustained release of compounds
#303TEMOZOLOMIDE POWDER FORMULATION
#304Biodegradable extended release microsphere-hydrogel ocular drug delivery system and method
#305Injectable Hormone Formulations for Estrous Cycle Control in Mammals, its Manufacturing Process, Estrous Cycle Control and Puberty Triggering Methods, and Pregnancy Enhancement in Mammals
#306Compositions and methods for ophthalmic and/or other applications
#307Compositions and methods for ophthalmic and/or other applications
#308Medicinal Composition for Treating Intractable Heart Disease
#309MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS
#310MEMBRANE EMULSIFICATION DEVICE FOR MICROSPHERE CREATION
#311Bi-functional co-polymer use for ophthalmic and other topical and local applications
#312Degradable removable implant for the sustained release of an active compound
#313Nonviral gene transfer to the suprachoroidal space
#314Block copolymer and micelle compositions and methods of use thereof
#315Ophthalmic delivery device and ophthalmic drug compositions
#316CYSTINE KNOT SCAFFOLD PLATFORM
#317Non-ionic surfactants for reducing fatty tissue
#318Encapsulation Methods and Compositions
#319THREE-DIMENSIONAL PRINTED STRUCTURAL SILOXANES HAVING CONTROLLED DRUG RELEASE
#320Multi-targeted multi-valent ligand drug particles for the treatment and prevention of diseases and conditions
#321Particles for targeted delivery and uses in managing bleeding or blood clotting
#322PHARMACEUTICAL FORMULATION
#323TIME RELEASED BIODEGRADABLE OR BIOERODIBLE MICROSPHERES OR MICROPARTICLES SUSPENDED IN A SOLIDIFYING DEPOT-FORMING INJECTABLE DRUG FORMULATION
#324Compositions and methods for ophthalmic and/or other applications
#325Polymer composed of repeat units having a biologically active molecule attached thereto via a pH-sensitive bond
#326Compositions and methods for ophthalmic and/or other applications
#327Cationic mucic acid polymer-based delivery systems
#328RISPERIDONE-CONTAINING MICROCAPSULE, METHOD FOR PREPARING SAME AND RELEASE CONTROL METHOD
#329LAYERED SUSTAINED-RELEASE MICROBEADS AND METHODS OF MAKING THE SAME
#330Sustained Release Pharmaceutical Compositions and Methods of Use
#331Nitro-oleic acid controlled release platform to induce regional angiogenesis in abdominal wall repair
#332Multiparticulate L-carnitine compositions and related methods
#333MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES
#334Delivery of hydrophobic active agent particles
#335Linear polyester and semi-linear glycidol polymer systems: formulation and synthesis of novel monomers and macromolecular structures
#336Cystine knot scaffold platform
#337EXTENDED RELEASE MICROPARTICLES AND SUSPENSIONS THEREOF FOR MEDICAL THERAPY
#338Method of making an in situ sustained biodegradable drug delivery implant by filling an artificial tissue cavity
#339SUSPENSIONS OF ENCAPSULATED PHARMACEUTICALS AND METHODS OF MAKING AND USING THE SAME
#340Modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders
#341Method for preparing micro-particles by double emulsion technique
#342POLYMERSOMES, COLLOIDOSOMES, LIPOSOMES, AND OTHER SPECIES ASSOCIATED WITH FLUIDIC DROPLETS
#343Immunothermosensitive Composite, Kit For Treating Cancer, And Use Thereof
#344Amphiphile-Polymer Particles
#345DIHYDROMYRICETIN NANOPARTICLE FORMULATIONS
#346CATIONIC NUCLEIC ACID SCAVENGER AND USES THEREOF
#347Microencapsulation process and product
#348Immediate release abuse-deterrent granulated dosage forms
#349THERAPEUTIC NANOPARTICLES ENCAPSULATING TERPENOIDS AND/OR CANNABINOIDS
#350Alginate microcapsules for cell and molecular therapy that secrete bioactive immune molecules
#351Cystine knot scaffold platform
#352Cystine knot scaffold platform
#353Microcapsules and methods of using the same
#354Pharmaceutical compositions comprising 4-(6BR,10AS)-3-methyl-2,3,6B,9,10,10A-hexahydro-1h, 7H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)butan-1-one and methods of treating conditions of the central nervous system
#355ION BINDING POLYMERS AND USES THEREOF
#356Method of Encapsulating Compounds
#357Amantadine compositions and preparations thereof
#358PHARMACEUTICAL FORMULATION AND SYSTEM AND METHOD FOR DELIVERY
#359Method to generate microcapsules with hexahydrotriazine (HT)-containing shells
#360Methods of delivering a neuroprotective polypeptide to the central nervous system
#361Process for the preparation of drug loaded microparticles
#362Stem cell biomimetic microparticles
#363DRY POWDER FORMULATIONS FOR MESSENGER RNA
#364COMPOSITIONS AND METHODS OF MANUFACTURING PROTEIN MICROPARTICLES
#365Modified polynucleotides for the production of secreted proteins
#366Stimuli-responsive micro-reservoirs for release of encapsulants
#367Oil-in-Oil emulsified polymeric implants containing a hypotensive lipid and related methods
#368PARTICLES, COMPOSITIONS, AND METHODS FOR OPHTHALMIC AND/OR OTHER APPLICATIONS
#369Buffered microencapsulated compositions and methods
#370Buffered microencapsulated compositions and methods
#371Meropenem derivatives and uses thereof
#372Buffered microencapsulated compositions and methods
#373STABLE MULTIPARTICULATE PHARMACEUTICAL COMPOSITION OF ROSUVASTATIN
#374Aggregating microparticles for medical therapy
#375Aggregating microparticles for medical therapy
#376Parenteral sustained-release delivery of carvedilol disperse systems
#377Topical formulation of hyperbranched polyglycerol-coated particles thereof
#378Magnetic nanoparticle delivery system for pain therapy
#379Hyperbranched polyglycerol-coated particles and methods of making and using thereof
#380Nanoparticle delivery system for targeted anti-obesity treatment
#381Drug delivery formulation for treating mental illness or central nervous system disorder
#382PARTICLES ENCAPSULATING FUSION PROTEINS CONTAINING LINKED EPITOPES
#383Implantable device for sustained release of a macromolecular drug compound
#384Implantable device for sustained release of a macromolecular drug compound
#385Tamper resistant oral opioid agonist formulations
#386PREVENTION OF LOCAL TUMOR RECURRENCE FOLLOWING SURGERY USING SUSTAINED AND/OR DELAYED RELEASE OF MEDICAMENTS CONTAINED IN MICRO-PARTICLES
#387Medicinal Composition for Treating Intractable Heart Disease
#388Risperidone sustained release microsphere composition
#389Micromotors and nanomotors for gastrointestinal diagnosis and treatment applications
#390NANOMATERIAL AND METHOD OF PRODUCTION OF A NANOMATERIAL FOR MEDICAL APPLICATIONS, SUCH AS MRI OR SERS
#391Pharmaceutical compositions of water soluble peptides with poor solubility in isotonic conditions and methods for their use
#392METHOD FOR PRODUCING A PARTICLE-SHAPED MATERIAL
#393Decreased adhesivity receptor-targeted nanoparticles for Fn14-positive tumors
#394SUSTAINED DELIVERY OF THERAPEUTIC AGENTS TO AN EYE COMPARTMENT
#395Modified polynucleotides for the production of secreted proteins
#396POROUS POLYMER MICROSPHERES FOR PREVENTING OR TREATING SOFT TISSUE DISEASES AND METHOD FOR MANUFACTURING THE SAME
#397Polymeric materials and articles manufactured there from
#398Delivery devices and methods for making the same
#399Aza-indazole compounds for use in tendon and/or ligament injuries
#400Method for preparing microcapsules and microparticles of controlled size
#401Pharmaceutical composition and use
#402Reduced permeability microcapsules
#403Compositions and methods for reducing overdose
#404PHARMACEUTICAL COMPOSITION COMPRISING AN ANTIEMETIC AGENT AND METHOD FOR THE PREPARATION THEREOF
#405Process for the preparation of microcapsules
#406Methods of using amantadine compositions
#407Crosslinked particles
#408COMPOSITION AND FOOD OR DRINK
#409CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#410Microencapsulation of bacteriophages and related products
#411Composition for treatment of infertility in a female subject
#412Ceria nanocomposite comprising ceria nanoparticle for treating subarachnoid hemorrhage, method for preparing same, and pharmaceutical composition
#413METHODS AND REAGENTS TO TREAT AUTOIMMUNE DISEASES AND ALLERGY
#414Pharmaceutical compositions with enhanced stability
#415Spherical microparticles with polyester walls
#416PHARMACEUTICAL COMPOSITIONS COMPRISING HYDROMORPHONE AND NALOXONE
#417Biomaterials for modulating immune responses
#418Particles, Compositions and Methods for Ophthalmic and/or Other Applications
#419Polycation-Functionalized Nanoporous Silicon Carrier for Systemic Delivery of Gene Silencing Agents
#420PHARMACEUTICAL COMPOSITIONS CONFIGURED TO DETER DOSAGE FORM SPLITTING
#421Cationic mucic acid polymer-based delivery system
#422NANOPARTICLES FOR DERMAL AND SYSTEMIC DELIVERY OF DRUGS
#423Therapeutic Agent Release System
#424COMPOSITION FOR DELIVERY OF ACTIVE AGENTS TO AN ANIMAL
#425Reloadable microcapsules
#426Treating soft tissue via controlled drug release
#427Compositions and methods for ophthalmic and/or other applications
#428System for delivery of FK506 for enhancing nerve regeneration
#429Microcapsules for controlled delivery of an active pharmaceutical ingredient
#430Sustained Release Pharmaceutical Compositions and Methods of Use
#431Therapeutic viral microparticles for promoting stent biofunctionality and wound healing in vertebrate individuals
#432THERMORESPONSIVE HYDROGEL CONTAINING POLYMER MICROPARTICLES FOR NONINVASIVE OCULAR BIOLOGIC DELIVERY
#433Buffered microencapsulated compositions and methods
#434Buffered microencapsulated compositions and methods
#435Crystallization inhibitor compositions for implantable urological devices
#436Controlled Release Dosage Form for Once Daily Administration of Dimethyl Fumarate
#437Pharmaceutical compositions of pimobendan
#438Pharmaceutical compositions of pimobendan
#439Controlled-release peptide compositions and uses thereof
#440Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl) butan-1-one for inhibiting serotonin reuptake transporter activity
#441Self-Emulsifying Compositions of CB2 Receptor Modulators
#442Use of polymeric excipients for lyophilization or freezing of particles
#443PSYCHIATRIC TREATMENT FOR PATIENTS WITH GENE POLYMORPHISMS
#444Methods, compositions, and devices for drug/live cell microarrays
#445Stimuli-responsive interpolymer complex coated hollow silica vesicles
#446Risperidone sustained release microsphere composition
#447COMPOSITIONS FOR SUSTAINED RELEASE OF ANTI-GLAUCOMA AGENTS TO CONTROL INTRAOCULAR PRESSURE
#448Hypercompressed pharmaceutical formulations
#449Process for encapsulating soluble biologics, therapeutics, and imaging agents
#450MULTILAYERED PHARMACEUTICALLY ACTIVE COMPOUND-RELEASING MICROPARTICLES IN A LIQUID DOSAGE FORM
#451Controlled Release Dosage Form for Once Daily Administration of Dimethyl Fumarate
#452Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
#453Particulate delivery systems
#454Polymer implants for treatment of metabolic disorders
#455Layered sustained-release microbeads and methods of making the same
#456Particle and pharmaceutical composition comprising an insoluble camptothecin compound with double core-shell structure and method for manufacturing the same
#457Multiparticulate L-carnitine compositions and related methods
#458Microcapsule comprising a polyester-urethane shell and a hydrophilic core material
#459Multiphasic particles fabricated by wettability engendered templated self-assembly (WETS) methods
#460DRUGS AND GENE CARRIER PARTICLES THAT RAPIDLY MOVE THROUGH MUCOUS BARRIERS
#461FUNCTIONALIZED POLYMERIC PARTICLES FOR TREATMENT OF GLIOMAS
#462Products containing charged polymer complex microcapsules and method of use
#463Microcapsule comprising a polyester-urethane shell and a hydrophobic core material
#464Method and Compounds for Treating Peripheral Neuropathy
#465Raloxifene sprinkle composition
#466Extended release microparticles and suspensions thereof for medical therapy
#467COATED BIOLOGICAL COMPOSITION
#468Use of hydrophobic organic acids to increase hydrophobicity of proteins and protein conjugates
#469Chamber for encapsulating secreting cells
#470TERNARY MIXTURE FORMULATIONS
#471Antigen-specific, tolerance-inducing microparticles and uses thereof
#472Aqueous systems of at least two phases containing microcapsules and processes for manufacturing the same
#473METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS
#474Block copolymer and micelle compositions and methods of use thereof
#475Cystine knot scaffold platform
#476Method and composition for enhancing the delivery of anti-platelet drugs for the treatment of acute stroke
#477Pharmaceutically effective composition for controlled drug delivery
#478Compositions and methods for ophthalmic and/or other applications
#479Engineered metal nanoparticles and methods thereof
#480Method to generate microcapsules with hexahydrotriazine (HT)-containing shells
#481PARTICLES, COMPOSITIONS AND METHODS FOR OPHTHALMIC AND/OR OTHER APPLICATIONS
#482Injectable and biodegradable polymer formulations for controlled release of bioactive agents
#483Pharmaceutical compositions of water soluble peptides with poor solubility in isotonic conditions and methods for their use
#484NEW DODECAPEPTIDES AND MICROCAPSULES FUNCTIONALISED WITH THEM TARGETED TO FIBROBLASTS
#485Compositions and layered structures formed therewith for regeneration of articular cartilage
#486Nanocrystals, compositions, and methods that aid particle transport in mucus
#487Compositions and methods for ophthalmic and/or other applications
#488Topical formulation of hyperbranched polymer-coated particles
#489Controlled release system including a gas or volatile encapsulated in a polymeric support and a matrix system, a method of preparing the system, and their use
#490SUSTAINED-RELEASE FORMULATION
#491Encapsulation
#492Multi-encapsulated formulations made with oxidized cellulose
#493POLYMERSOMES, LIPOSOMES, AND OTHER SPECIES ASSOCIATED WITH FLUIDIC DROPLETS
#494ORAL LIQUID COMPOSITIONS OF GUANFACINE
#495EXTENDED RELEASE SUSPENSION COMPOSITIONS
#496Sol-gel phase-reversible hydrogel templates and uses thereof
#497Method for manufacturing a therapeutic agent for use in the treatment of infections
#498Buffered microencapsulated compositions and methods
#499Buffered microencapsulated compositions and methods
#500BIORESORBABLE DRUG DELIVERY MATRICES BASED ON CROSS-LINKED POLYSACCHARIDES, DOSAGE FORMS DESIGNED FOR DELAYED/CONTROLLED RELEASE
#501Method of synthesis of silica vesicles and use thereof
#502Immediate release abuse-deterrent granulated dosage forms
#503Biodegradable Microcapsules Containing Filling Material
#504Topical formulation of hyperbranched polyglycerol-coated particles thereof
#505MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF NUCLEAR PROTEINS
#506Dual assembly nanoparticles
#507MECHANO-SENSITIVE MICROCAPSULES FOR DRUG DELIVERY
#508Microcapsules modified with nanomaterial for controlled release of active agent and process for preparation thereof
#509Bi-functional co-polymer use for ophthalmic and other topical and local applications
#510Sustained delivery of therapeutic agents to an eye compartment
#511Self-inflating microcapsules
#512Linear polyester and semi-linear glycidol polymer systems: formulation and synthesis of novel monomers and macromolecular structures
#513Delivery of hydrophobic active agent particles
#514Hydrogen peroxide-activable, anti-oxidant compounds and methods using same
#515POWDER COATING COMPOSITIONS FOR COATING PHARMACEUTICAL PELLETS
#516Raloxifene sprinkle composition
#517Drug delivery composition comprising polymer-lipid hybrid microparticles
#518MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE
#519Biodegradable, semi-crystalline, phase separated, thermoplastic multi block copolymers for controlled release of biologically active compounds
#520Biodegradable polymeric particles encapsulating an active agent, pharmaceutical compositions and uses thereof
#521Compositions and methods for ophthalmic and/or other applications
#522Biodegradable polymer formulations for extended efficacy of botulinum toxin
#523Tamper resistant oral opioid agonist formulations
#524Buffered microencapsulated compositions and methods
#525Core-shell capsules for encapsulation of particles, colloids, and cells
#526USE OF MTOR INHIBITORS TO PREVENT AND REGRESS EDHESIONS AND FIBROSIS
#527Modified polynucleotides for the production of oncology-related proteins and peptides
#528Complex particles for delivering nitric oxide, method of producing the same, and application of the same
#529Methods for treating tauopathy
#530Controlled release from particles encapsulated by molecular layer deposition
#531Biomimetic drug delivery of an immunomodulatory agent for the treatment of ocular conditions
#532Polymer implants for treatment of metabolic disorders
#533Disulfide Polymers and Methods of Use
#534Implantable medical devices having double walled microspheres
#535Nanoparticle delivery system for targeted anti-obesity treatment
#536Multilayer Biodegradable Microparticles for Sustained Release of Therapeutic Agents
#537Meropenem derivatives and uses thereof
#538Microcapsules comprising a water-immiscible core and a wall comprising the salt of a lewis acid and a lewis base
#539PHARMACEUTICAL FORMULATION HAVING REVERSE THERMAL GELATION PROPERTIES FOR LOCAL DELIVERY OF NANOPARTICLES
#540LONG ACTING PHARMACEUTICAL COMPOSITIONS FOR HEPATITIS C
#541Process for preparing microcapsules having a polyurea shell and a lipophilic core material
#542Sustained Release Formulation and Use Thereof
#543Block copolymer and micelle compositions and methods of use thereof
#544Pharmaceutical formulations of xanthine or xanthine derivatives, and their use
#545Combination long acting compositions and methods for Hepatitis C
#546Long Acting Pharmaceutical Compositions For Hepatitis C
#547Amphiphile-polymer particles
#548Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activity
#549Drug-containing particulate composition with cationic agent, associated medical devices, and methods for treatment
#550SYSTEMS, DEVICES, AND METHODS FOR SUBCUTANEOUS THERAPEUTIC TREATMENT
#551INJECTABLE MICROSPHERES
#552Core-shell particle
#553Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
#554LIPOLYTIC METHODS
#555Nanocrystals, compositions, and methods that aid particle transport in mucus
#556Hyperbranched polyglycerol-coated particles and methods of making and using thereof
#557Compositions and methods for reducing overdose
#558Encapsulation Methods and Compositions
#559Long acting pharmaceutical compositions
#560NUCLEIC ACIDS, AND USES THEROF
#561Pharmaceutical compositions of water soluble peptides with poor solubility in isotonic conditions and methods for their use
#562Polymer composed of repeat units having a biologically active molecule attached thereto via a pH-sensitive bond
#563Matrix and layer compositions for protection of bioactives
#564DENDRIMERS FOR SUSTAINED RELEASE OF COMPOUNDS
#565Lithographically defined nanoparticles for microwave absorption
#566PHARMACEUTICAL COMPOSITION
#567Pharmaceutical composition containing leuprolide and having both immediate and sustained release properties
#568THERAPEUTIC NANOPARTICLES FOR THE TREATMENT OF NEUROBLASTOMA AND OTHER CANCERS
#569Polymer protein microparticles
#570Loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
#571Sustained-release composition and method for producing the same
#572Glucocorticoid-loaded nanoparticles for prevention of corneal allograft rejection and neovascularization
#573METHODS AND COMPOSITIONS FOR ENHANCED DRUG DELIVERY TO THE EYE AND EXTENDED DELIVERY FORMULATIONS
#574Compositions and Methods for Delivery of Poorly Soluble Drugs
#575Nanoparticulate and macroparticulate formulations
#576STANNOUS DOPED MICRO AND NANO PARTICLES FOR AUGMENTED RADIOFREQUENCY ABLATION
#577Pharmaceutical composition and use
#578Aggregating microparticles for medical therapy
#579Cystine knot scaffold platform
#580SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE
#581Nanocrystals, compositions, and methods that aid particle transport in mucus
#582Ternary mixture formulations
#583BIOPOLYMER-ENCAPSULATED GLYCOSYL TRANSFERASE INHIBITOR COMPOSITIONS AND METHODS FOR TREATING DIABETES AND CARDIAC INDICATIONS
#584Encapsulation
#585Delivery of hydrophobic active agent particles
#586Nanoparticulate complex of nicotine and cerium oxide and use thereof
#587Crosslinked particles
#588Use of nanoparticles coated with red blood cell membranes to treat hemolytic diseases and disorders
#589Biodegradable microsphere-hydrogel ocular drug delivery system
#590Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders
#591Therapeutic agent for use in the treatment of infections
#592Drug delivery product for controlled drug delivery
#593COPOLYMERS OF FORMULA (I) AND USES
#594Compositions and methods for reducing overdose
#595Composition of nanoformulated lycopene and method of using the composition
#596Nanoparticle compositions
#597Risperidone sustained release microsphere composition
#598Stable multiparticulate pharmaceutical composition of rosuvastatin
#599Microcapsule formulation and method for producing the same
#600Bioerodible silicon-based compositions for delivery of therapeutic agents